Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 13.3

(-2.56%)

Operating Income Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual operating income in 2023 was -45.69 Million TWD , down -39.72% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly operating income in 2024 Q2 was -10.19 Million TWD , down 0.0% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported an annual operating income of -30.85 Million TWD in 2022, down -482.3% from previous year.
  • Mercury Biopharmaceutical Corporation reported an annual operating income of -5.29 Million TWD in 2021, down -2422.86% from previous year.
  • Mercury Biopharmaceutical Corporation reported a quarterly operating income of -10.19 Million TWD for 2024 Q1, up 22.77% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a quarterly operating income of -9.64 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Operating Income of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -45.69 Million TWD -39.72%
2022 -30.85 Million TWD -482.3%
2021 -5.29 Million TWD -2422.86%
2020 -210 Thousand TWD 0.0%
2019 - TWD 0.0%

Peer Operating Income Comparison of Mercury Biopharmaceutical Corporation

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 151.503%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 129.753%
Easywell Biomedicals, Inc. -162.73 Million TWD 71.924%
TTY Biopharm Company Limited 1.37 Billion TWD 103.329%
Synmosa Biopharma Corporation 614.74 Million TWD 107.432%
Orient EuroPharma Co., Ltd. 84.55 Million TWD 154.036%
Center Laboratories, Inc. -79.26 Million TWD 42.358%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD 323.576%
Orient Pharma Co., Ltd. 27.75 Million TWD 264.631%
InnoPharmax Inc. -64.83 Million TWD 29.533%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 143.279%
Excelsior Biopharma Inc. -81.12 Million TWD 43.682%
DV Biomed Co., Ltd. 173.54 Million TWD 126.327%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 95.466%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 106.567%
UniPharma Co., Ltd. -27.3 Million TWD -67.332%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD 185.959%
Alar Pharmaceuticals Inc. 385.52 Million TWD 111.851%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 123.299%
Bioray Biotech Co., Ltd -19.33 Million TWD -136.356%
TSH Biopharm Corporation Limited 63.63 Million TWD 171.806%